Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tauriga Sciences Inc (CE) | TAUG | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.000001 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.000001 | 0.000001 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.000001 - 0.0129 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.000001 | USD |
Tauriga Sciences Inc (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 348.90 | 348.90M | 203.49M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 3.06k | $ - | - | - | - |
Tauriga Sciences (CE) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TAUG Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.000001 | 0.000001 | 0.000001 | 0.000001 | 128,786 | 0.00 | 0.0% |
| 1 Month | 0.000001 | 0.000001 | 0.000001 | 0.000001 | 109,254 | 0.00 | 0.0% |
| 3 Months | 0.000001 | 0.000001 | 0.000001 | 0.000001 | 36,057 | 0.00 | 0.0% |
| 6 Months | 0.0001 | 0.0001 | 0.000001 | 0.0000416 | 82,489 | -0.0001 | -99.0% |
| 1 Year | 0.01025 | 0.0129 | 0.000001 | 0.0064139 | 440,857 | -0.01025 | -99.99% |
| 3 Years | 0.0335 | 0.1985 | 0.000001 | 0.0763848 | 1,331,995 | -0.0335 | -100.0% |
| 5 Years | 0.0006 | 1.00 | 0.000001 | 0.0560311 | 1,245,300 | -0.0006 | -99.83% |
Tauriga Sciences (CE) Description
| Tauriga, a life sciences company, manufactures and distributes several proprietary retail products and product lines, focusing on the Cannabidiol ("CBD") and Cannabigerol ("CBG") edibles market segment. The main product line, branded as Tauri-Gum TM, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified and Vegan Formulated (CBD Infused Tauri-Gum TM; Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum TM Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc "Immune Booster" Tauri-Gum TM Flavor: Pear Bellini). The Company has also developed and sells a Gelatin Free, CBD Infused Gum Drop Product, branded as: Tauri-Gummies TM. The Company's commercialization strategy consists of a retail customers, distributors, and a fast-growing E-Commerce business segment (www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com. The Company's ongoing Pharmaceutical Development initiative relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum TM, for nausea regulation of Patients Subjected to Ongoing Chemotherapy Treatment). On March 22, 2021, the Company announced that it had Converted its U.S. Provisional Patent Application (March 17, 2020) into a U.S. Non-Provisional Patent Application. The Patent, filed with the U.S.P.T.O. is Titled "MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT". |